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Abstract: Among Herpesviruses, Human Cytomegalovirus (HCMV or HHV-5) represents 
a major threat during congenital or neonatal infections, which may lead to encephalitis with 
serious neurological consequences. However, as opposed to other less prevalent pathogens, 
the mechanisms and genetic susceptibility factors for CMV encephalitis are poorly 
understood. This lack of information considerably reduces the prognostic and/or therapeutic 
possibilities. To easily monitor the effects of genetic defects on brain dissemination 
following CMV infection we used a recently developed in vivo mouse model based on the 
neonatal inoculation of a MCMV genetically engineered to express Luciferase. Here, we 
further validate this protocol for live imaging, and demonstrate increased lethality associated 
with viral infection and encephalitis in mutant mice lacking Dicer activity. Our data indicate 
that miRNAs are important players in the control of MCMV pathogenesis and suggest that 
miRNA-based endothelial functions and integrity are crucial for CMV encephalitis. 
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1. Introduction 
Human Cytomegalovirus (HCMV/HHV-5), a member of the β-herpesvirus family, is highly prevalent 
in the population and usually acquired during early life as an asymptomatic infection [1]. Like all 
herpesviruses, HCMV exhibits life-long persistence without viral replication in immunocompetent hosts. 
However, immunosuppression may lead to viral reactivation, as observed in transplant patients receiving 
drugs to prevent graft rejection [2]. In adults, HCMV has also been linked to glioblastomas [3]. 
Importantly, HCMV is also a prominent pathogen in newborns where the immune system is still 
immature [4–6]. Primary infection in the developing fetus or neonate can have severe consequences, 
such as microcephaly or cerebellar hypoplasia. Current estimates indicate that neonatal HCMV infection 
affects 0.5%–1% of all live births, of which 5%–10% will suffer from severe symptoms. As it stands, 
HCMV infection is the most common infectious cause of congenital birth defects and childhood disorders in 
developed countries. In addition, 10% of infected infants with subclinical viral infection will later develop 
sequellae leading to mental retardation, hearing loss, visual defects or seizure and epilepsy [7,8]. 
While a number of mutations responsible for the occurrence of neonatal Herpes Simplex 1  
(HSV-1/HHV-1) encephalitis have been identified in humans [9], no genetic loci have so far been 
identified for HCMV, even though indirect evidence indicates that IL-12 and Type I interferons may be 
important players [10]. This discrepancy is likely related to the species specificity of HCMV—Indeed, 
as opposed to HSV-1, which can be inoculated to mice via different routes [11], non-human cells and 
organisms cannot support HCMV replication. Therefore, investigations on cytomegalovirus pathogenesis 
can only be performed in various animal models (mouse, rat, guinea pig, rhesus monkey) infected by 
their respective genuinely host-specific CMVs. In this regard, the mouse/MCMV interaction proved to 
be one of the best host—Pathogen models because of the significant similarities in genome size and 
organization, tissue tropism and regulation of gene expression between the murine and human viruses. 
These features provided considerable help in the identification of genes involved in CMV pathogenesis 
during infections in adults [12–14] reviewed in [15]. It must be noted that analysis of congenital CMV 
infection in mice appears to be more complex than analyzing the human form as the organization of the 
placental layers differs between the two species, with mother-to-fetus viral transmission being impaired 
in mice. Inducement of brain infection in mouse neonates, which in turn leads to hearing impairment, 
has been obtained upon direct injection of MCMV in the placenta on day 12.5 of gestation [16]. Most 
investigators, however, favor intraperitoneal injection of newborn (4–20 h-old) mice to provide systemic 
viral dissemination, which potentially leads to brain infection via the hematogenous route. This infection 
model proves to be more relevant than intracranial injection, as it provides important insights into 
MCMV encephalitis, especially in evidencing viral replication in neuronal and glial cells located in 
inflammatory foci which have been infiltrated with mononuclear cells, for example macrophages [17]. 
Previous work also reported altered morphogenesis of the cerebellum together with reduced granular 
neuron proliferation and migration as well as induction of multiple Interferon-stimulated genes, and further 
implicated that control of MCMV replication in the central nervous system requires CD8+T cells [18]. 
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To gather more insight into genes and pathways involved in MCMV-dependent neonatal encephalitis 
we used our recently developed imaging technology based on the detection of a genetically-engineered 
MCMV expressing Luciferase (MCMV-Luc) to monitor and quantify viral replication in vivo [19]. 
Using this protocol, which allows for live imaging—Thus reducing the number of mice necessary for 
experimental infections [20]—We addressed the mechanisms of viral dissemination in the brain upon 
peritoneal infection of newborns. We focused these studies on the processing of microRNAs (miRNAs), 
i.e., the 21–23 nucleotide non-coding RNAs which are—Among others—Major players in defense 
mechanisms [21]. Indeed, the recent discovery of virally-encoded miRNAs in the genome of large DNA 
viruses such as CMV [22–24] has considerably raised interest in these molecules in the context of  
virus–Host interactions. Therefore, we investigated the impact of a mutation in the Dicer gene, which is 
crucial for miRNA biogenesis [25], on the evolution of an intraperitoneal MCMV infection of newborn 
mice. In accordance with our previous observations in adults indicating that miRNAs are important 
players in antiviral defense [26], we here report increased mortality of Dicer-deficient neonates 
following viral inoculation. We also observed higher viral dissemination and replication in the brain of 
mutant pups compared to the wild-type, suggesting that miRNA biogenesis represents a previously 
unsuspected defense mechanism against Herpesvirus encephalitis. 
2. Results 
2.1. Impaired miRNA Biogenesis Induces Increased Lethality in MCMV-Infected Mouse Neonates 
To evaluate the role of miRNAs on MCMV pathogenesis in newborns we first infected wild-type and 
Dicer-deficient (Dicer d/d, [26,27]) 4–8 h-old pups with a highly pathogenic Smith strain of MCMV  
(i.e., isolated from the salivary glands of infected Balb/c females) and monitored their survival. As shown 
in Figure 1A, postnatal development of wild-type mice was severely affected by the intraperitoneal (i.p.) 
injection of a small amount (50 p.f.u—Forming units) of MCMV, with all pups dying by day 11  
post-inoculation. However, mortality was significantly (***, p = 0.0001) higher in mice carrying the 
Dicer d/d hypomorphic mutation. Virally-induced lethality is accompanied by decreased weight gain of 
both control and mutant pups compared to uninfected animals (Supplementary Figure S1A). To 
demonstrate that reduced Dicer expression is indeed responsible for this decreased viability upon viral 
infection in neonates we used a recombinant virus (MCMV-Cre), which allows for the expression of the 
Cre recombinase during the viral cycle. Injecting 4–8 h-old pups with this virus led to limited lethality 
in control wild-type mice (Dicer +/+), most likely reflecting a reduced pathogenicity of the MCMV-Cre 
amplified in cultured cells. However, infection of Dicer fl°x/fl°x newborns led to significantly (p = 0.0343) 
increased lethality (Figure 1B) which, interestingly, is also accompanied by lower weight gain in the 
infected animals (Supplementary Figure S1B). The late onset of lethality in Dicer-floxed mice (starting 
at day 15) probably reflects the delay in the reduction of Dicer expression, as this requires gene excision 
and significant decrease in transcript and protein abundance. These experiments indicate that normal  
Dicer-dependent miRNA biogenesis is a crucial feature driving MCMV resistance. Furthermore, increased 
lethality of infected Dicer fl°x/fl°x neonates suggests that the mechanism is cell-autonomous and restricted 
to MCMV infected cells as it cannot be compensated by normal Dicer expression in non-infected cells. 
Viruses 2015, 7 2311 
 
 
 
Figure 1. Increased lethality of Dicer-deficient newborns upon MCMV infection.  
(A). Control (Dicer +/+, N = 7) and mutant (Dicer d/d, N = 13) 4–8 h old neonates were infected 
by intraperitoneal injection of 50 p.f.u of MCMV (Smith strain, prepared in vivo). Survival of 
the pups was monitored every 12 h. (B). Dicer +/+ (N = 11) and Dicer flox/flox (N = 10) were infected 
with 500 p.f.u of a recombinant MCMV-Cre (prepared by amplification in NIH 3T3 cells). 
2.2. Increased Viral Replication in Dicer-Deficient Newborns 
To quantify viral replication in vivo we used a Luciferase-expressing MCMV (MCMV-Luc).  
4–8 h-old wild-type (Dicer +/+) and mutant (Dicer d/d) neonates were inoculated i.p. with 500 p.f.u of this 
weakly pathogenic virus, after which viral amplification was monitored by way of Luciferin injection 
and subsequent quantification of light emission. In vivo imaging and data collection were performed on 
anesthetized pups at days 7, 9, 12, and 14 as described [19]. As seen in Figure 2A, while all pups of 
various Dicer genotypes (+/+; d/+ or d/d) exhibit similar Luciferase expression at day 4, imaging of the 
same animals at later time points reveals regular decrease of light emission in those carrying wild-type 
and heterozygous Dicer alleles. One Dicer +/d neonate died likely as a result of anesthesia. Remarkably 
however, the two Dicer d/d homozygous mutants identified in the litter used in this experiment exhibited 
sustained viral replication until day 14. A semi-quantitative representation of the light emitted by each 
animal is shown in Figure 2B, which clearly illustrates continuous viral gene expression in Dicer d/d 
neonates from day 7 to day 14. This indicates that while efficient viral clearance is observed in control 
animals, such mechanisms are lacking in pups with low Dicer expression. Similar data were obtained in 
2 additional independent experiments in which the neonates were infected 12 h (Supplementary  
Figure S2A) or 24 h after birth (Supplementary Figure S2B). A compilation of the luminescence 
quantified for the different animals in these 3 experiments confirms increased viral replication in Dicer d/d 
neonates (Supplementary Figure S2C). 
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Figure 2. In vivo imaging reveals increased MCMV replication in infected Dicer-deficient 
neonates. (A). Snapshot images showing the luminescence emitted by MCMV-Luc-infected 
animals 7, 9, 12 and 14 days after infection. The genotype of the animals is indicated.  
(B). time-course analysis of luminescence (expressed in Log photons/sec or p/s) quantified 
for each animal presented in A. Wild-type control (Dicer +/+, animal n° 2 in yellow), 
heterozygotes (Dicer +/d, animals 3, 4 and 6 in red) and mutants (Dicer d/d, animals 1 and 5 
in blue). 
2.3. Preferential Viral Dissemination in the Brain of Dicer-Deficient Newborns 
Live imaging of MCMV replication with high levels in large organs such as the lungs, spleen or liver 
may mask more discrete activity domains. We therefore masked the luminescence originating from the 
abdomen (using thick, dark cardboard) in order to detect a potential luminescent signal from the head 
alone, allowing the monitoring of possible viral replication in the brain. Increasing the length of the 
detection period enabled us to detect photons emitted in a discrete area at the ear level (Figure 3, red 
arrow). Interestingly, such a signal was visible only in Dicer d/d animals. To identify whether the brain 
is the source of this luminescence we euthanized the animals and recorded the light emitted from the 
dissected brains. As shown in Figure 4, strong signals are clearly visible in brains from Dicer d/d mutants, 
whereas a control brain shows negligible light emission. Quantification of these signals confirmed a 
marked (one Log) difference in signal intensity. Comparable results were obtained upon qPCR 
quantification of the viral genome (following the procedure described in [26]) in dissected brains 
harvested from a pool of MCMV-infected neonates (representing different experiments) at day 12.  
As shown in Suppl. Figure 3, increased (although not significant) viral replication can be observed in 
Dicer d/d mice. Surprisingly, one control neonate exhibited high viral titer in the brain, which can be the 
consequence of fortuitous hemorrhage during virus intraperitoneal injection and subsequent 
dissemination. Furthermore, the dissected brains were also used in RT-qPCR quantification (data not 
shown) to determine that Dicer expression is significantly reduced in mutants, which is similarly 
observed in other tissues [26,27]. 
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Figure 3. Preferential viral dissemination in the head of Dicer d/d mutants following MCMV 
neonatal infection. The abdomen of the animals was covered with dark cardboard to hide 
luminescence emitted from the lungs, spleen, liver or kidneys in order to increase the 
exposure time and to detect photons originating from the head region only. Data were 
obtained at days 7, 9, 12, and 14 following MCMV-Luc injection. Genotypes are indicated. 
To unambiguously demonstrate the presence of the virus in the brain and to locate its replication sites 
we performed Immunohistochemistry (IHC) staining on frozen brain sections from MCMV-inoculated 
Dicer +/+ and Dicer d/d neonates. By using an antibody directed against the E1 protein (CROMA 103 Ab) 
we evidenced MCMV infection in the posterior brain region (bregma-3.08) in Dicer d/d mutants, which 
corresponds to the luminescent sites (Figure 5A,E). No staining was observed in the corresponding area 
of control brains (i.e., from infected wild-type mice). Interestingly, mutant brains stained strongly not 
only in foci as illustrated for the retrosplenial cortex (compare Figure 5B–F and C–G), but also in the 
alveus of the hippocampus or in individual, dispersed cells in the granular layers of the hippocampus 
(compare Figure 5B–F and D–H). Although Nissl often co-localized with E1 protein in our experiment 
(Figure 5G,H), in good agreement with a previous report [28] showing that neurons are the primary 
target of MCMV infection in the brain, we cannot exclude that other cell types were also infected. We 
particularly observed frequent staining in elongated, epithelial-like cells in blood vessels of Dicer d/d 
brains (arrow in Figure 5H). Further immunofluorescence analyses revealed that the MCMV E1 protein 
was localized in nuclei (as detected by DAPI staining) in both the cortex (Figure 6A–C) and the 
hippocampus (Figure 6D–F). 
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Figure 4. Increased brain infection in Dicer d/d mutants. (A). Snapshot image illustrating 
luminescence from the dissected brains harvested in a representative control neonate  
(Dicer +/+) and two Dicer d/d mutants. (B). Luminescence (expressed in photons/sec or p/s) 
was quantified and plotted for each brain. 
 
Figure 5. Immunohistochemistry reveal specific localization of MCMV in the brain of 
infected Dicer d/d neonates. (A) and (E). Snapshot images showing luminescence emitted by 
a control (Dicer +/+) and a mutant (Dicer d/d) brains respectively. Examples of 
immunohistochemical detection of E1 protein in Dicer +/+ (B–D) and Dicer d/d brains (F–H) 
include macroscopic images (B), (F) and magnifications of selected regions of retrosplinal 
cortex (Cx; (C), (G)) and hippocampus (H; (D), (H)) at Bregma–3.08 mm. 
Immunolocalization of MCMV using the CROMA 103 primary antibody and peroxidase-
labeled secondary antibody was depicted in brown and cresyl violet neuronal detection in 
blue. Epithelial staining in blood vessels is indicated by the arrow. 
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Figure 6. Nuclear detection of E1 protein in Dicer d/d mouse brain. Examples of 
immunofluorescent detection of E1 protein in the cortex ((A)–(D); Bregma—3.08mm) and 
hippocampus ((E)–(H); Bregma—2.3 mm) of Dicer d/d brain using CROMA 103 antibody. 
Magnifications of boxed regions illustrate E1 expression (B), (F), DAPI staining of the 
nuclear DNA (C), (G) and their colocalisation (D), (H). 
3. Discussion 
Neonatal infections by Cytomegalovirus induce major defects in multiple organs potentially causing 
premature death. Among the most severe complications that can occur are those associated with 
neurological dysfunctions (e.g., deafness or mental retardation). Due to their high prevalence  
CMV-related diseases in children represent a heavy burden; however the molecular mechanisms 
involved in CMV neuropathogenesis are less investigated than those caused by other herpesviruses.  
Data obtained by genetic analyses in children suffering Herpes Simplex 1 (HSV1) encephalitis provided 
clues on the physiopathology associated with this viral infection, leading to the identification of several 
genes involved in innate antiviral responses. Among these genes, those encoding for Tlr3 [29] or  
Unc-93B [30] could also be involved in the defense against other Herpesviruses such as CMV, even 
though this assumption has not been formally demonstrated. Additionally, mutations in these genes are 
extremely rare in the population and account for only a small fraction of neonatal HSV-1 diseases of 
genetic origin. Therefore, we used a preclinical approach and developed an in vivo imaging tool to screen 
for genetic (or pharmacological) factors in mice which affect MCMV dissemination to the nervous 
system, with the aim of identifying novel genes and pathways involved in CMV-related neurological 
abnormalities. In this report we describe increased lethality following intraperitoneal injection of 
MCMV in newborn mice where miRNA biogenesis was altered as a consequence of a hypomorphic 
mutation of the Dicer gene. Interestingly, we also observed a higher viral gene expression (as revealed 
by luciferase detection in the case of MCMV-Luc or E1 protein upon IHC experiments), reflecting [31] 
augmented virus titers in the brain of Dicer-deficient neonates. A precise localization of viral replication 
sites by IHC staining confirmed the viral infection of neurons localized in different cortical regions, 
including the entorhinal cortex and the hippocampus—Two areas tightly associated with cognitive 
functions [32]. While our work cannot directly link the increased death rate of the animals to the presence 
of MCMV in their brains we do however provide strong evidence for a major role of miRNAs in 
resistance to the infection. miRNAs are now considered as major regulators of gene expression and their 
role in antiviral immunity has been assessed in mammals [33–35], with our own work providing 
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important insights into their role in the innate defense against viruses in adult mice [26,27]. However, 
the role of miRNAs in Herpesvirus infections is by nature difficult to investigate as they function both 
in the host immune defense as well as possible pathogenic factors encoded by the viral genomes. 
Therefore, studying MCMV infection in Dicer-deficient neonates, which are characterized by the 
relative immaturity of their immune system [18], provides for an interesting opportunity to understand 
the relative importance of both host and virally-encoded immune miRNAs. It can be concluded from our 
data that their role as pathogenic factors (whose decrease would be expected to lower MCMV 
aggressiveness) is dominated by that of host miRNAs (which likely exert protective functions). Several 
hypotheses can be drawn to account for the increased susceptibility of Dicer d/d neonates to MCMV 
infection and the virus’s preferential brain localization:  
(i) A global innate immune alteration could be the consequence of low miRNA biogenesis, thereby 
provoking uncontrolled viral replication. During these conditions, high viral load in the brain would 
simply reflect increased viral titers in organs such as the lungs, the kidneys or the spleen. In other words, 
high viral loads in the periphery would automatically drive a CNS infection. We do not favor this 
possibility because, as seen in Figure 2A, mouse number 2 (Dicer +/+) exhibits very high luciferase levels 
in the abdomen (similar to those observed for Dicer d/d animals) and yet brain infection was not observed. 
Alternatively, we support a model in which. 
(ii) miRNA expressed by endothelial cells play a major role in the process of viral dissemination in 
the brain. This is supported by the fact that MCMV replicates in these cells, contributing to viral 
dissemination [36]. Furthermore, miRNAs are important actors of endothelial cell functions [37].  
Taking into account these observations, we speculate that endothelium perturbations in the blood-brain 
barrier represent a major issue, leading to MCMV leakage into the brain of Dicer d/d neonates.  
Because endothelium dysfunction can be either intrinsic to the Dicer d/d mutants or a consequence of 
MCMV infection future experiments aiming at exploring the integrity of the blood-brain barrier will be 
of high interest. 
4. Materials and Methods 
4.1. Mice and Ethics Statement 
Animals were maintained under pathogen-free conditions in the animal care facility of the  
Institut d’Immunologie et d’Hématologie. Handling of mice and experimental procedures were 
conducted in accordance with the French Law for the Protection of Laboratory Animals. The procedure 
was approved by the service véterinaire de la Préfecture du Bas-Rhin (France) under the authorization 
number A-67-345. Dicerd/d mice were described in [26,27]. Dicer fl°x/fl°x animals were described in [38]. 
4.2. Viruses 
The MCMV Smith strain was amplified in vivo by three consecutive propagations in 3 week-old 
BALB/c females infected with 1 × 104 plaque-forming units (p.f.u). Two weeks after intraperitoneal 
injection, salivary glands were harvested and homogenized in DMEM. Viral titers were quantified by plaque 
assay as previously described [39]. MCMV-Luc and MCMV-Cre (both provided by Lars Dölken, University 
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of Cambridge, Cambridge, UK) were amplified in cultured NIH 3T3 cells and quantified by plaque assay in 
the same cells as described [39]. The insertion site of the Luc and Cre genes is reported in [40]. 
4.3. In Vivo Imaging 
Infection of neonates and data acquisition of luminescence on an IVIS-50 (Caliper) were carried out 
as described [19]. Snapshot images and luminescence quantification (expressed in photons/sec—p/s) 
was performed with the dedicated software Living Image. 
4.4. Immunohistochemistry Staining 
Brains dissected from 14 days-old neonates were fixed overnight at +4 °C in 4% paraformaldehyde 
(PFA), washed in PBS and dehydrated by consecutive incubations in 70%, 95% and absolute ethanol 
followed by histosol. 7 µm thick coronal sections were prepared from paraffin embedded brains and 
collected on Superfrost Plus® slides. For immunohistochemistry paraffin was removed and sections 
rehydrated in a series of baths including histosol followed by absolute, 95%, 70%, and 50% ethanol 
solutions, with subsequent termination by PBS incubation. Epitope retrieval was carried out by heating 
in citrate buffer (0.01 M, pH 6) with a microwave oven for 10 min, while endogenous peroxidase was 
inactivated by incubation in H2O2 1% in PBS, with non-specific sites saturated by incubation in Fetal 
Calf Serum (FCS) 7%. Primary antibody (CROMA 103; diluted 1/100; gift from Stipan Jonjic, School 
of Medicine, University of Rijeka, Croatia) was used to detect viral E1 protein and the signal was 
revealed using an ABC kit (Vector Laboratories, AbCys SA, France) according to the manufacturer’s 
protocol. Immunofluorescence experiments were performed using secondary antibody coupled with 
Alexa488 and DAPI for detection of nuclear DNA. Cresyl violet was used in counterstaining. 
4.5. Statistical Analysis 
GraphPad Prism 5.04 was used to perform statistical analysis of survival curves using Log-rank 
(Mantel-Cox) Test. Mann-Whitney (non parametric) test was used to compare two unmatched groups. 
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